Abstract
Evidence indicates that neoadjuvant chemotherapy (NAC) may promote antitumour immune responses by activating T cells. The tumour-draining sentinel node (SN) is a key site to study tumour-specific T cell activation, being the primary immunological barrier against the tumour. In this prospective study, we set out to elucidate the effects of NAC on T cell subsets in the SNs of patients with muscle-invasive urothelial bladder cancer. We found that CD8+ effector T (Teff) cell exhaustion was reduced after NAC treatment, while cytotoxicity was increased. Additionally, in complete responders (CR patients), these cells were functionally committed effectors, as displayed by epigenetic analysis. In CD4+ Teffs, NAC treatment was associated with increased clonal expansion of tumour-specific SN-derived cells, as demonstrated by a specific cell reactivity assay. In contrast, we observed an attenuating effect of NAC on regulatory T cells (Tregs) with a dose-dependent decrease in Treg frequency and reduced effector molecule expression in the remaining Tregs. In addition, multicolour flow cytometry analysis revealed that CR patients had higher Teff to activated Treg ratio, promoting antitumoural T cell activation. These results suggest that NAC ...Continue Reading
Citations
Oct 28, 2019·Oncoimmunology·Sara WahlinKarin Jirström
Jan 22, 2020·Scandinavian Journal of Urology·Robert RosenblattAmir Sherif
Sep 3, 2020·International Journal of Molecular Sciences·Juan Carlos PardoAlbert Font
Nov 25, 2019·World Journal of Urology·Julia AlvaeusAmir Sherif
Sep 11, 2019·Nature Reviews. Urology·Anna K SchneiderLaurent Derré
Apr 21, 2020·BioMed Research International·Fuqing ZhangWenhua Chen
Apr 23, 2020·Journal of Translational Medicine·Ulf GunnarssonCaj Haglund
May 28, 2019·World Journal of Urology·Helene JungMarianne Brehmer
Nov 18, 2019·BMC Urology·Wasilijiang WahafuNianzeng Xing
Sep 25, 2020·Cancers·Sandra van WilpeNiven Mehra
Apr 22, 2020·Oncoimmunology·Zewei WangJiejie Xu
Jan 4, 2021·Cancer Chemotherapy and Pharmacology·Chuan-Kun ShanYong-Su Zhen
Mar 30, 2021·OncoTargets and Therapy·Nobuki FurubayashiMotonobu Nakamura
Sep 27, 2020·Nature Communications·Ann TaberLars Dyrskjøt
Nov 23, 2021·Scandinavian Journal of Urology·Danna AsadAmir Sherif
Jan 22, 2022·Journal of Cancer Research and Clinical Oncology·Se Young ChoiHasung Kim